<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Rapid overview: Emergency management of supraventricular tachycardia in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Rapid overview: Emergency management of supraventricular tachycardia in children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Rapid overview: Emergency management of supraventricular tachycardia in children</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="subtitle1_single" colspan="2">Evaluation</td> </tr> <tr> <td colspan="2"> <p>Provide oxygen and ventilation immediately as needed.</p> Goals – Identify the unstable patient; distinguish SVT from sinus tachycardia.</td> </tr> <tr> <td class="subtitle2_single" colspan="2">Clinical assessment</td> </tr> <tr> <td colspan="2"> <ul class="decimal_heading"> <li>Potential causes of sinus tachycardia (dehydration, fever, pain, drugs).</li> <li>Signs of poor perfusion (poor capillary refill, hypotension, pallor, diminished mental status).</li> <li>Signs of heart failure (increased work of breathing, rales, hepatomegaly).</li> </ul> </td> </tr> <tr> <td class="subtitle2_single" colspan="2">ECG*</td> </tr> <tr> <td colspan="2"> <ul class="decimal_heading"> <li>The following are consistent with SVT: <ul> <li>Rate – Infants 220 to 280 bpm; children and adolescents 180 to 240 bpm.</li> <li>Relentlessly regular rhythm without variation with respiration or activity.</li> <li>Abnormal P waves (absent or negative in II, III, and aVF).</li> <li>For wide QRS complex, assume the origin is ventricular (although in children, most are SVT with aberrant conduction)<sup>¶</sup>.</li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle1_single" colspan="2">Management</td> </tr> <tr> <td colspan="2">Goal – Terminate the abnormal rhythm. Consult pediatric cardiology early.</td> </tr> <tr> <td class="subtitle2_single">Stable</td> <td class="subtitle2_single">Unstable</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Children with SVT who are stable are unlikely to deteriorate suddenly.</li> <li>Begin treatment with vagal maneuvers and/or adenosine and consult pediatric cardiology.</li> </ul> </td> <td> <ul class="decimal_heading"> <li>For unstable patients (depressed consciousness, poor perfusion, hypotension, or other signs of shock or severe heart failure), begin treatment to convert to sinus rhythm immediately.</li> <li>Continue oxygen and ventilation as needed.</li> </ul> </td> </tr> <tr> <td> <ul class="decimal_heading"> <li><strong>Vagal maneuvers</strong> – For infants, apply bag containing ice water to the face above the nose and mouth for 15 to 30 seconds. Do not obstruct ventilation. In older children, bearing down or blowing into an occluded straw for 15 to 20 seconds provides vagal stimulation. Do <strong>not</strong> use carotid massage or orbital pressure.</li> </ul> </td> <td> <ul class="decimal_heading"> <li><strong>Vagal maneuvers</strong> – Do not delay treatment to administer vagal maneuvers in unstable patients. Attempt while preparing for cardioversion or drug therapy.</li> </ul> </td> </tr> <tr> <td rowspan="2"> <ul class="decimal_heading"> <li><strong>Adenosine</strong> – With continuous ECG monitoring, administer rapidly through IV closest to the central circulation. Initial dose: 0.1 mg/kg (maximum 6 mg); if no response in 2 minutes, repeat dose 0.2 mg/kg (maximum 12 mg). Follow each dose immediately with a saline flush of 5 mL<sup>Δ</sup>.</li> </ul> </td> <td> <ul class="decimal_heading"> <li><strong>Without IV/IO in place:</strong> <ul> <li><strong>Synchronized cardioversion</strong> – Cardiovert immediately all unstable patients without IV access. Use 0.5 to 1 J/kg. If not effective, increase to 2 J/kg.</li> </ul> </li> </ul> </td> </tr> <tr> <td> <ul class="decimal_heading"> <li><strong>With IV/IO in place</strong><sup>◊</sup><strong>:</strong> <ul> <li><strong>Adenosine</strong> – If immediately available, adenosine may be given to unstable patients with narrow complex SVT with IV access while preparing to cardiovert. Initial dose is 0.1 mg/kg (maximum 6 mg); if no response in 2 minutes, repeat dose 0.2 mg/kg (maximum 12 mg). Follow each dose immediately with a saline flush of 5 mL<sup>Δ</sup>.</li> <li><strong>Synchronized cardioversion</strong> – If adenosine is not immediately available or if there is no response to adenosine, synchronized cardioversion should be performed in all unstable patients with IV access. Use 0.5 to 1 J/kg. If not effective, increase to 2 J/kg.</li> <li><strong>IV antiarrhythmic options for refractory SVT</strong> – Alternative second-line agents that have been used in this setting include IV amiodarone, IV esmolol, IV procainamide, IV sotalol, and IV verapamil (in patients ≥1 year old). Choice of a second-line agent should be guided by expert consultation, given potential proarrhythmic and life-threatening hemodynamic collapse when administering multiple antiarrhythmic agents.<sup>§</sup></li> </ul> </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>SVT: supraventricular tachycardia; ECG: electrocardiogram; bpm: beats per minute; IV: intravenous; IO: intraosseous; J/kg: joule per kilogram.</p>
<p>* A 15-lead ECG is preferred. This includes the 12 standard leads plus leads V3R and V4R (right-sided leads analogous to V3 and V4 on the left) and V7 (left posterior axillary line at V4 level). If a 15-lead ECG is not available, a standard 12-lead ECG is acceptable. ECG monitoring should continue during therapeutic maneuvers.</p>
<p>¶ Refer to separate UpToDate content for details of evaluation and management of wide QRS complex tachyarrhythmias in children.</p>
<p>Δ The use of 2 syringes (1 with adenosine and the other with normal saline flush) connected to a stopcock is a useful way of ensuring rapid and effective drug delivery.</p>
<p>◊ IV access is preferred over IO for administration of adenosine and antiarrhythmic drugs. An IO can be used for these agents, but conversion to sinus rhythm with adenosine may not be successful when using IO access.</p>
§ Consultation with a pediatric cardiologist is advised. Refer to UpToDate content on management of tachyarrhythmias in children for further details.</div><div id="graphicVersion">Graphic 53559 Version 17.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
